← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Inhibikase Therapeutics
Atlanta, GA
$13,026,031
Total funding
7
Grants
Funding over time
peak $3.6M · FY2009–21$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$13,026,031 · 7
By mechanism
R44$11,752,318 · 3
R43$1,273,713 · 4
Investigators at Inhibikase Therapeutics
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Advanced therapeutic for Parkinson's Disease$1,554,563
R44 · FY2018 · NS
Advanced therapeutic for Parkinson's Disease$1,554,108
R44 · FY2019 · NS
Advanced therapeutic for Parkinson's Disease$1,554,020
R44 · FY2017 · NS
Advanced therapeutic for Parkinson's Disease$1,546,730
R44 · FY2020 · NS
Advanced Prodrug Treatment for CML$1,016,040
R44 · FY2018 · CA
Advanced PML antiviral$1,000,000
R44 · FY2018 · AI
Advanced PML antiviral$1,000,000
R44 · FY2017 · AI
Advanced Prodrug Treatment for CML$985,960
R44 · FY2019 · CA
Novel DFG out inhibitors of Abl-kinases to treat PML$787,776
R44 · FY2016 · AI
Novel DFG out inhibitors of Abl-kinases to treat PML$753,121
R44 · FY2015 · AI
Kinase activation in multiple system atrophy$385,888
R43 · FY2021 · NS
DFG-out inhibitors of Abl-kinases to treat PML$300,000
R43 · FY2013 · AI
Prodrug treatment for CML$284,778
R43 · FY2017 · CA
PML antiviral for AIDS$265,846
R43 · FY2009 · NS
PML antiviral for AIDS$37,201
R43 · FY2010 · NS